Dr. Mehmet Oz holds millions of dollars worth of shares in health insurance, fertility, pharmaceutical and vitamin companies.

The FDA determined that Novo Nordisk’s obesity and diabetes drugs are no longer in short supply. Elsewhere, Concentra made a ...

Interim CEO Brent Shafer said the medical products maker is ready to begin a new era after several years of “heavy lifting” ...

In turn, this could actually bring a new wave of long-term growth for Nvidia. Palantir CEO Alex Karp recently shared some interesting thoughts on the DeepSeek development. Alex Karp is a PhD., ...

Processa Pharmaceuticals, Inc. announced its participation in the 2025 BIO CEO & Investor Conference taking place on February 10-11, 2025, in New York City. The company's management will present a ...

Feb. 07, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals ... today announced its participation in the 2025 BIO CEO & Investor Conference being held February 10-11, 2025, at the New York Marriott ...

Using the 2 Stage Free Cash Flow to Equity, Sonoma Pharmaceuticals fair value estimate is US$1.97 Sonoma Pharmaceuticals is estimated to be 34% overvalued based on current share price of US$2.65 ...

Using the 2 Stage Free Cash Flow to Equity, Sonoma Pharmaceuticals fair value estimate is US$1.97 Sonoma Pharmaceuticals is estimated to be 34% overvalued based on current share price of US$2.65 ...

Rodriguez, the CEO and President of Rigel Pharmaceuticals Inc. (NASDAQ:RIGL), recently sold shares worth $200,075, according to a recent ... Finally, in the third quarter of 2024, Rigel achieved a net ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of development candidates, today announced that Seth ...

Investors interested in arranging a meeting with the Company’s management during the conference can register on the BIO CEO & Investor Conference website here. Tonix Pharmaceuticals Holding Corp ...